A direct intersection between p53 and transforming growth factor β pathways targets chromatin modification and transcription repression of the α-fetoprotein gene

Molecular and Cellular Biology

Volumn 25, Issue 3, 2005, Pages 1200-1212

  Wilkinson, Deepti S ^a   Ogden, Stacey K ^b,c   Stratton, Sabrina A ^a   Piechan, Julie L ^b,d   Nguyen, Thi T ^a   Smulian, George A ^b   Barton, Michelle Craig ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; COMPLEMENTARY DNA; HISTONE DEACETYLASE; PLASMID DNA; PROTEIN P53; RECOMBINANT PROTEIN; SMAD PROTEIN; SMAD4 PROTEIN; SMALL INTERFERING RNA; SNON PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN; GENE REPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

ACETYLATION; ALPHA-FETOPROTEINS; ANIMALS; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; HELA CELLS; HISTONES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; METHYLATION; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; SMAD2 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 12844270613     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.3.1200-1212.2005     Document Type: Article

References (89)

1. Akiyoshi, S., H. Inoue, J. Hanai, K. Kusanagi, N. Nemoto, K. Miyazono, and M. Kawabata. 1999. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J. Biol. Chem. 274:35269-35277.
2. Andrisani, O. M., and S. Barnabas. 1999. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int. J. Oncol. 15:373-379.
3. Ashcroft, M., Y. Taya, and K. H. Vousden. 2000. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol. 20:3224-3233.
4. Attisano, L. 2000. Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12:235-243.
5. Bargonetti, J., and J. J. Manfredi. 2002. Multiple roles of the tumor suppressor p53. Curr. Opin. Oncol. 14:86-91.
6. Berk, M., S. Y. Desai, H. C. Heyman, and C. Colmenares. 1997. Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development. Genes Dev. 11:2029-2039.
7. Blain, S. W., and J. Massague. 2000. Different sensitivity of the transforming growth factor-beta cell cycle arrest pathway to c-Myc and MDM-2. J. Biol. Chem. 275:32066-32070.
8. Boyer, P. L., C. Colmenares, E. Stavnezer, and S. H. Hughes. 1993. Sequence and biological activity of chicken snoN cDNA clones. Oncogene 8:457-466.
9. Camper, S. A., and S. M. Tilghman. 1991. The activation and silencing of gene transcription in the liver. Bio/Technology 16:81-87.
10. Carmen, A. A., S. E. Rundlett, and M. Grunstein. 1996. HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. J. Biol. Chem. 271:15837-15844.
11. Carter, M. S., S. Li, and M. F. Wilkinson. 1996. A splicing-dependent regulatory mechanism that detects translation signals. EMBO J. 15:5965-5975.
12. Chadee, D. N., M. J. Hendzel, C. P. Tylipski, C. D. Allis, D. P. Bazett-Jones, J. A. Wright, and J. R. Davie. 1999. Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts. J. Biol. Chem. 274:24914-24920.
13. Chang, H., C. W. Brown, and M. M. Matzuk. 2002. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 23:787-823.
14. Chang, H., A. L. Lau, and M. M. Matzuk. 2001. Studying TGF-beta superfamily signaling by knockouts and knockins. Mol. Cell. Endocrinol. 180:39-46.
15. Chaya, D., T. Hayamizu, M. Bustin, and K. S. Zaret. 2001. Transcription factor FoxA (HNF3) on a nucleosome at an enhancer complex in liver chromatin. J. Biol. Chem. 276:44385-44389.
16. Chen, H., J. O. Egan, and J. F. Chiu. 1997. Regulation and activities of alpha-fetoprotein. Crit. Rev. Eukaryot. Gene Expr. 7:11-41.
17. Choi, J., and L. A. Donehower. 1999. p53 in embryonic development: maintaining a fine balance. Cell. Mol. Life Sci. 55:38-47.
18. Cohen, S. B., G. Zheng, H. C. Heyman, and E. Stavnezer. 1999. Heterodimers of the SnoN and Ski oncoproteins form preferentially over homodimers and are more potent transforming agents. Nucleic Acids Res. 27:1006-1014.
19. Colmenares, C., H. A. Heilstedt, L. G. Shaffer, S. Schwartz, M. Berk, J. C. Murray, and E. Stavnezer. 2002. Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski-/- mice. Nat. Genet. 30:106-109.
20. Cordenonsi, M., S. Dupont, S. Maretto, A. Insinga, C. Imbriano, and S. Piccolo. 2003. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113:301-314.
21. Crowe, A. J., and M. C. Barton. 1999. Functional analysis of chromatin assembled in synthetic nuclei. Methods 17:173-187.
22. Crowe, A. J., and M. C. Barton. 1999. In vitro reconstitution of nuclei for replication and transcription. Methods Enzymol. 304:63-76.
23. Crowe, A. J., J. L. Piechan, L. Sang, and M. C. Barton. 2000. S-phase progression mediates activation of a silenced gene in synthetic nuclei. Mol. Cell. Biol. 20:4169-4180.
24. Crowe, A. J., L. Sang, K. K. Li, K. C. Lee, B. T. Spear, and M. C. Barton. 1999. Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the α-fetoprotein gene. J. Biol. Chem. 274:25113-25120.
25. Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29:117-129.
26. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
27. Dkhissi, F., S. Raynal, P. Jullien, and D. A. Lawrence. 1999. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein. Oncogene 18:703-711.
28. Dunker, N., and K. Krieglstein. 2000. Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 267:6982-6988.
29. Feitelson, M. A., M. Zhu, L. X. Duan, and W. T. London. 1993. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109-1117.
30. Germain, S., M. Howell, G. M. Esslemont, and C. S. Hill. 2000. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev. 14:435-451.
31. Gerwin, B. I., E. Spillare, K. Forrester, T. A. Lehman, J. Kispert, B. Vogelstein, and C. C. Harris. 1992. Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor β1. Proc. Natl. Acad. Sci. USA 89:2759-2763.
32. Gorski, K., M. Carneiro, and U. Schibler. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767-776.
33. Hall, P. A., and D. P. Lane. 1997. Tumor suppressors: a developing role for p53? Curr. Biol. 7:R144-R147.
34. Haviv, I., D. Vaizel, and Y. Shaul. 1996. pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J. 15:3413-3420.
35. Hemann, M. T., J. S. Fridman, J. T. Zilfou, E. Hernando, P. J. Paddison, C. Cordon-Cardo, G. J. Hannon, and S. W. Lowe. 2003. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 33:396-400.
36. Hill, C. S. 2001. TGF-beta signalling pathways in early Xenopus development. Curr. Opin. Genet. Dev. 11:533-540.
37. Hsia, C. C., D. J. Kleiner, C. A. Axiotis, B. A. Di, A. M. Nomura, G. N. Stemmermann, and E. Tabor. 1992. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. J. Natl. Cancer Inst. (Bethesda) 84:1638-1641.
38. Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875-886.
39. Jones, S. N., A. E. Roe, L. A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 8:206-208.
40. Kho, P. S., Z. Wang, L. Zhuang, Y. Li, J. L. Chew, H. H. Ng, E. T. Liu, and Q. Yu. 2004. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J. Biol. Chem. 279:21183-21192.
41. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
42. Lee, K. C., A. J. Crowe, and M. C. Barton. 1999. p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol. Cell. Biol. 19:1279-1288.
43. Levine, A. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
44. Li, Y., C. M. Turck, J. K. Teumer, and E. Stavnezer. 1986. Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J. Virol. 57:1065-1072.
45. Liu, X., Y. Sun, R. A. Weinberg, and H. F. Lodish. 2001. Ski/Sno and TGF-β signaling. Cytokine Growth Factor Rev. 12:1-8.
46. Luo, K. 2004. Ski and SnoN: negative regulators of TGF-β signaling. Curr. Opin. Genet. Dev. 14:65-70.
47. Luo, K., S. L. Stroschein, W. Wang, D. Chen, E. Martens, S. Zhou, and Q. Zhou. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev. 13:2196-2206.
48. Massague, J. 1998. TGF-beta signal transduction. Annu. Rev. Biochem. 67:753-791.
49. Massague, J., S. W. Blain, and R. S. Lo. 2000. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
50. Massague, J., and D. Wotton. 2000. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19:1745-1754.
51. Medrano, E. E. 2003. Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Oncogene 22:3123-3129.
52. Melino, G., X. Lu, M. Gasco, T. Crook, and R. A. Knight. 2003. Functional regulation of p73 and p63: development and cancer. Trends Biochem. Sci. 28:663-670.
53. Montes de Oca Luna, R., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-206.
54. Moustakas, A., and D. Kardassis. 1998. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells hy functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95:6733-6738.
55. Nomura, T., M. M. Khan, S. C. Kaul, H. D. Dong, R. Wadhwa, C. Colmenares, I. Kohno, and S. Ishii. 1999. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev. 13:412-423.
56. Ogden, S. K., K. C. Lee, and M. C. Barton. 2000. Hepatitis B viral transactivator HBx alleviates p53-mediated repression of α-fetoprotein gene expression. J. Biol. Chem. 275:27806-27814.
57. Ogden, S. K., K. C. Lee, K. Wernke-Dollries, S. A. Stratton, B. Aronow, and M. C. Barton. 2001. p53 targets chromatin structure alteration to repress α-fetoprotein gene expression. J. Biol. Chem. 276:42057-42062.
58. Pearson-White, S., and M. McDuffie. 2003. Defective T-cell activation is associated with augmented transforming growth factor β sensitivity in mice with mutations in the Sno gene. Mol. Cell. Biol. 23:5446-5459.
59. Qin, B. Y., S. S. Lam, J. J. Correia, and K. Lin. 2002. Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control. Genes Dev. 16:1950-1963.
60. Reed, J. A., E. Bales, W. Xu, N. A. Okan, D. Bandyopadhyay, and E. E. Medrano. 2001. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Cancer Res. 61:8074-8078.
61. Rorke, E. A., D. Zhang, C. K. Choo, R. L. Eckert, and J. W. Jacobberger. 2000. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression. Exp. Cell Res. 259:149-157.
62. Roth, S. Y., J. M. Denu, and C. D. Allis. 2001. Histone acetyltransferases. Annu. Rev. Biochem. 70:81-120.
63. Ryan, T. M., R. R. Rehringer, N. C. Martin, T. M. Townes, R. D. Palmiter, and R. L. Brinster. 1989. A single erythroid-specific DNase I super-hypersensitive site activates high levels of human β-globin gene expression in transgenic mice. Genes Dev. 3:314-323.
64. Scherr, M., M. A. Morgan, and M. Eder. 2003. Gene silencing mediated by small interfering RNAs in mammalian cells. Curr. Med. Chem. 10:245-256.
65. Schutze, N. 2004. siRNA technology. Mol. Cell. Endocrinol. 213:115-119.
66. Shi, Y. 2003. Mammalian RNAi for the masses. Trends Genet. 19:9-12.
67. Shi, Y., and J. Massague. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
68. Shih, W.-L., M.-L. Kuo, S.-E. Chauang, A.-L. Cheng, and S.-L. Doong. 2000. Hepatitis B virus X protein inhibits transforming growth factor-beta induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 275:25858-25864.
69. Shinagawa, T., H. D. Dong, M. Xu, T. Maekawa, and S. Ishii. 2000. The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice. EMBO J. 19:2280-2291.
70. Shinagawa, T., T. Nomura, C. Colmenares, M. Ohira, A. Nakagawara, and S. Ishii. 2001. Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice. Oncogene 20:8100-8108.
71. Sirotkin, H. I., M. A. Gates, P. D. Kelly, A. F. Schier, and W. S. Talbot. 2000. Fast1 is required for the development of dorsal axial structures in zebrafish. Curr. Biol. 10:1051-1054.
72. Spear, B. T., T. Longley, S. Moulder, S. L. Wang, and M. L. Peterson. 1995. A sensitive lacZ-based expression vector for analyzing transcriptional control elements in eukaryotic cells. DNA Cell Biol. 14:635-642.
73. Stroschein, S. L., W. Wang, S. Zhou, Q. Zhou, and K. Luo. 1999. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science 286:771-774.
74. Sun, Y., X. Liu, E. Eaton, W. S. Lane, H. F. Lodish, and R. A. Weinberg. 1999. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol. Cell 4:499-509.
75. ten Djike, P., K. Miyazono, and C.-H. Heldin. 2000. Signaling inputs converge on nuclear effectors in TGF-β signaling. Trends Biochem. Sci. 25:64-70.
76. Teramoto, T., A. Kiss, and S. S. Thorgeirsson. 1998. Induction of p53 and Bax during TGF-beta 1 initiated apoptosis in rat liver epithelial cells. Biochem. Biophys. Res. Commun. 251:56-60.
77. Tilghman, S. M. 1985. The structure and regulation of the alpha-fetoprotein and albumin genes. Oxf. Surv. Eukaryotic Genes 2:160-206.
78. Truant, R., J. Antunovic, J. Greenblatt, C. Prives, and J. A. Cromlish. 1995. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J. Virol. 69:1851-1859.
79. Turner, B. M. 2000. Histone acetylation and an epigenetic code. Bioessays 22:836-845.
80. Uchida, T., K. Takahashi, K. Tatsuno, U. Dhingra, and J. F. Eliason. 1996. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes. Int. J. Cancer 67:892-897.
81. Ueki, N., and M. J. Hayman. 2003. Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling. J. Biol. Chem. 278:32489-32492.
82. Ueki, N., and M. J. Hayman. 2003. Signal-dependent N-CoR requirement for repression by the Ski oncoprotein. J. Biol. Chem. 278:24858-24864.
83. Wahl, G. M., and A. M. Carr. 2001. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat. Cell Biol. 3:E277-E286.
84. Wang, L., Q. Wu, P. Qiu, A. Mirza, M. McGuirk, P. Kirschmeier, J. R. Greene, Y. Wang, C. B. Pickett, and S. Liu. 2001. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem. 276:43604-43610.
85. Wang, W., F. V. Mariani, R. M. Harland, and K. Luo. 2000. Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. Proc. Natl. Acad. Sci. USA 97:14394-14399.
86. Wells, J., C. R. Graveel, S. M. Hartley, S. J. Madore, and P. J. Farnham. 2002. The identification of E2F1-specific target genes. Proc. Natl. Acad. Sci. USA 99:3890-3895.
87. Wu, J. W., A. R. Krawitz, J. Chai, W. Li, F. Zhang, K. Luo, and Y. Shi. 2002. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling. Cell 111:357-367.
88. Zaret, K. S. 1994. Genetic control of hepatocyte differentiation, p. 53-68. In I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jakoby, D. A. Schachter, and D. A. Shafritz (ed.), The liver: biology and pathobiology, 3rd ed. Raven Press, New York, N.Y.
89. Zawel, L., J. L. Dai, P. Buckhaults, S. Zhou, K. W. Kinzler, B. Vogelstein, and S. E. Kern. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1:611-617.